Skip to content
Home/Contractors/Lovelace Biomedical Research Institute

Federal Contractor Profile

Lovelace Biomedical Research Institute

Federal contracting record: $137M obligated across 169 awards from 6 agencies, FY 2016–2026.

$137M
Total Obligated
169
Award Records
6
Agencies Served
14
NAICS Codes

Company Profile

Parent UEI (Unique Entity Identifier)

MBT9RXJJ7428

CAGE Code

4BSR8

Registered Entities (UEIs)

3 under this organization

Address

1101 YALE BLVD NE, ALBUQUERQUE, NM, 871063834

First Federal Award

Oct 6, 2015

Most Recent Award

Sep 15, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

Top NAICS Activity

  • 541380

    TESTING LABORATORIES AND SERVICES

    10 awards

    $49M
  • 541712

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)

    38 awards

    $24M
  • 541715

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

    33 awards

    $20M
  • 541711

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

    31 awards

    $16M
  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    21 awards

    $15M
  • 541690

    OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES

    5 awards

    $7.3M
  • 541720

    RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES

    4 awards

    $3.2M
  • 511210

    SOFTWARE PUBLISHERS

    4 awards

    $1.8M
  • 541990

    ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES

    4 awards

    $976K
  • 561320

    TEMPORARY HELP SERVICES

    2 awards

    $25K

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Sep 14, 2026Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS541690NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY$3.0M
Aug 21, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1$3.7M
Aug 5, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541715CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN$351K
Jul 17, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES$22K
Jun 22, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541715EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT$303K
May 29, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.$86K
May 29, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541712NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)$1.3M
May 7, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])$148K
Apr 1, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA$55K
Sep 30, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.$10K
Sep 22, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])$2.0M
Sep 19, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS541380SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).$7.1M
Aug 27, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA$139K
Jul 17, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES$21K
Jul 9, 2025Department of DefenseARMY MED RES ACQ ACTIVITY511210LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.$42K
Jun 30, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS541380STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.$9.8M
May 19, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541712NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)$1.7M
Sep 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541715CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021$133K
Sep 17, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541715CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022$121K
Aug 27, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI54138024-015894 NHLBI POPULATION SCIENCES BRANCH REQUIRES PULMONARY FUNCTION TESTING TO DETERMINE IF THE FLEXIVENT METHOD OF PULMONARY FUNCTION TESTING IS SUITABLE TO BE USED IN A LARGER STUDY.$17K
Aug 19, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022$48K
Aug 14, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])$1.7M
Aug 6, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA541714KICK-OFF MEETING FOR THE PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT IDIQ CONTRACT.$1K
Aug 1, 2024Department of DefenseARMY MED RES ACQ ACTIVITY511210LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.$225K
Jul 18, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES$37K

Want to win work like Lovelace Biomedical Research Institute?

Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.